Malin Life Sciences Holdings Ltd, Ten Percent Owner Other at Poseida Therapeutics, Inc. (PSTX), bought 51,458 shares at $6.77 ($363K) on 2021-11-23, disclosed to the SEC on 2021-11-23.
Open-market purchase of $363k PSTX by Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.44 | 11,104 | $83K | 22.7% |
| 2 | $7.44 | 11,104 | $83K | 22.7% |
| 3 | $6.77 | 14,625 | $99K | 27.3% |
| 4 | $6.77 | 14,625 | $99K | 27.3% |
| Total | $7.06 avg | 51,458 | $363K | 100% |
| Filing → |
| PSTX | BUY | 2021-12-02 | $673K | — | Filing → |
| PSTX | BUY | 2021-11-29 | $531K | — | Filing → |
| PSTX | BUY | 2021-11-18 | $5.5M | — | Filing → |